Get started
Author

G Cullen

Psoriasis associated with anti‐tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature
2011 · G. Cullen, D. Kroshinsky, et al. · Alimentary Pharmacology & Therapeutics · 205
Appendectomy for Therapy-Refractory Ulcerative Colitis Results in Pathological Improvement of Colonic Inflammation: Short-Term Results of the PASSION Study
2018 · S Sahami, M E Wildenberg, et al. · Journal of Crohn s and Colitis · 68
PDF
Prospective cohort study of appendicectomy for treatment of therapy-refractory ulcerative colitis
2019 · M E Stellingwerf, S Sahami, et al. · British journal of surgery · 51
Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines
2013 · J. D. Feuerstein, M. Akbari, et al. · Alimentary Pharmacology & Therapeutics · 49
PDF
Increased non‐melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single‐centre cohort study
2017 · J. Clowry, J. Sheridan, et al. · Journal of the European Academy of Dermatology and Venereology · 22
PDF
Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study
2018 · C. R. Rowan, D. Keegan, et al. · Alimentary Pharmacology & Therapeutics · 17
PDF
Letter: vedolizumab for the management of inflammatory bowel disease in patients after liver transplantation for primary sclerosing cholangitis
2016 · K. Hartery, S. O'Reilly, et al. · Alimentary Pharmacology & Therapeutics · 16
PDF
Colorectal Serrated Neoplasia: An Institutional 12-Year Review Highlights the Impact of a Screening Programme
2019 · A. J. McCarthy, S. M. O’Reilly, et al. · Gastroenterology Research and Practice · 9
PDF
P336 TNF alpha inhibitor use in pregnancy: experience in a European cohort
2014 · O. Kelly, K. Hartery, et al. · Journal of Crohn s and Colitis · 6
P0398 Point of Care Intestinal ultrasound – is it the key to reducing the carbon footprint of IBD Care?
2025 · M Nwaezeigwe, M Hanley, et al. · Journal of Crohn s and Colitis · 5
PDF
P040 Reduced serological response to COVID-19 vaccines in patients with IBD is further diminished by TNF inhibitor therapy; Early results of the VARIATION study (VAriability in Response in IBD Against SARS-COV-2 ImmunisatiON)
2022 · J Doherty, R Stack, et al. · Journal of Crohn s and Colitis · 3
PDF
P452 Medium to long-term outcomes in patients receiving accelerated dose infliximab induction for acute severe ulcerative colitis (ASUC) in a multi-centre cohort
2018 · D Gibson, M McNally, et al. · Journal of Crohn s and Colitis · 3
P640 Serum ustekinumab levels achieved with a subcutaneous induction regimen correlate to clinical outcome – a prospective study
2017 · C.R. Rowan, A. Kalei, et al. · Journal of Crohn s and Colitis · 3
P267 Prospective validation of the IBD - Distribution, Chronicity, Activity (DCA) histological score for Ulcerative Colitis and correlation with UCEIS and MES
2024 · D Egong, M Hanly, et al. · Journal of Crohn s and Colitis · 2
PDF
P597 Effectiveness and safety of vedolizumab therapy in an ulcerative colitis cohort with significant prior anti-TNF exposure
2018 · C Judge, N McGettigan, et al. · Journal of Crohn s and Colitis · 2
P582 Vedolizumab: Effects on liver function in an IBD and IBD/PSC cohort
2018 · J Doherty, M Buckley, et al. · Journal of Crohn s and Colitis · 2
P261 Grading post-operative recurrence in Crohn's disease: a comparison between MRE and ileocolonoscopy
2017 · A. Lavelle, D. Keegan, et al. · Journal of Crohn s and Colitis · 2
Predictors of Colectomy in Hospitalised Patients With Acute Severe Colitis
2013 · D J Gibson, N Rafter, et al. · Gut · 2
PDF
P1300 HLA-C*06 Genotype and Ustekinumab Therapy Persistence in Inflammatory Bowel Disease
2025 · R Corcoran, A Ryan, et al. · Journal of Crohn s and Colitis · 1
P452 Tofacitinib Effectiveness and Safety as Therapy for Ulcerative Colitis
2022 · M McNally, E Keating, et al. · Journal of Crohn s and Colitis · 1
PDF
P721 Early vedolizumab trough levels are associated with induction therapy outcome
2020 · J O’Connell, R Corcoran, et al. · Journal of Crohn s and Colitis · 1
PDF
P271 Trends in faecal calprotectin levels during pregnancy and post-partum in healthy women
2020 · J Doherty, R Moore, et al. · Journal of Crohn s and Colitis · 1
PDF
P329 Utility of faecal calprotectin to assess Crohn’s disease activity in patients with an ileostomy
2018 · C R Rowan, S Alzubi, et al. · Journal of Crohn s and Colitis · 1
P578 Therapy refractory ulcerative colitis patients may benefit from appendectomy: long-term clinical results from a multicentre prospective cohort series
2018 · M E Stellingwerf, S Sahami, et al. · Journal of Crohn s and Colitis · 1
P387 Factors associated with successful rescue therapy with infliximab for acute severe ulcerative colitis
2012 · Z. Heetun, K. Nanda, et al. · Journal of Crohn s and Colitis · 1
Works count: 61
Citation count: 474
H-index: 8
I10-index: 7
Year
Topic
Type